Alastair Garfield serves as Executive at RHYTHM PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Alastair Garfield has executed 3 insider transactions totaling $85.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2025 involved selling 6 shares valued at $388.
Alastair Garfield currently holds 3,126 shares of RHYTHM PHARMACEUTICALS, INC. (RYTM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alastair Garfield has been a net seller of RYTM stock. They have purchased $0 and sold $85.5K worth of shares.
Alastair Garfield's most recent insider trade was on Jul 2, 2025, when they sold 6 shares at $64.60 per share.
Get notified when new Form 4 filings are submitted
| $64.81 |
| Discretionary |
| Jul 1, 2025 | RYTM | $0 | Option Exercise | 4,445 | $N/A | Discretionary |